(Reuters) -Germany's Merck KGaA on Thursday said it had struck a deal with U.S. President Donald Trump that would cut the cost of some drugs needed for an in-vitro fertilization treatment cycle. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback